Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty, Decompression & minimally invasive spine.
All companies · Product and company coverage
In 2025, Spineart reported engagement with 134 surgeons and other clinicians in the states MedaRep covers, worth $34K in consulting, speaking, meals and travel for its device products, the most in California ($15K to 45). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($15K, 45 engaged), Texas ($3,085, 17 engaged), Idaho ($2,272, 5 engaged), Florida ($1,361, 6 engaged), Massachusetts ($1,240, 6 engaged).
In the last ten years FDA made 27 decisions for Spineart (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2026 (5). The latest was on 2026-09-22.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 37 |
| Cervical fusion & disc arthroplasty | 17 |
| Decompression & minimally invasive spine | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-22 | PMA | P250042-S002 | BAGUERA®C Cervical Disc Prosthesis · Postapproval Study Protocol |
| 2026-08-27 | PMA | P250042-S001 | BAGUERA®C Cervical Disc Prosthesis · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-08-20 | 510(k) | K261049 | SCALA® TL |
| 2026-08-10 | PMA | P250042 | BAGUERA®C Cervical Disc Prosthesis · Prosthesis, intervertebral disc |
| 2026-05-01 | 510(k) |
| K253966 |
| PERLA® TL Posterior Thoraco-lumbar Fixation System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Spineart.